"The most beautiful thing we experience is the mysterious. It is the source of all true art and all sciences. He to whom this emotion is a stranger, who can no longer pause to wonder and stand rapt in awe, is as good as dead: his eyes are closed."

-Albert Einstein, Ph.D.-

THE MACHINE

Cytotron® is the trade name given to a device that uses Rotational Field Quantum Magnetic Resonance (RFQMR) which has been developed by Centre for Advanced Research and Development (CARD), a division of Scalene Cybernetics in Bangalore, India. It is a new device used in regenerative and degenerative tissue engineering and repair. The Cytotron® is now being used for treating diseases like Osteoarthritis and Cancer. The treatment modality is non-invasive, painless and free from side effects. In the Clinical studies it has been demonstrated that Cytotron® is very effective in treating certain conditions such as a damaged knee by regenerating the cartilage tissue in Osteoarthritis or stopping and reversing the growth of a tumor in cancer.
     
back to top

SCIENCE INVOLVED
RFQMR produces high powered multi-frequency, high energy spinning quantum electromagnetic beams in the lower end of the EM spectrum in the Sub-Radio and Near-Radio Frequencies. In this frequency range, the effects are predominantly non-thermal because the intensity is not high enough to significantly change tissue temperature. Non-thermal effects are direct interactions of RF with biological cells. The Cytotron® Device will deliver the programmed precise dose of RF beams in the 1Khz to 100 MHz Range in the presence of high instantaneous magnetic field, which is then focused in the near field, using special antennae.

CARD engineers by simulation established that, when a biological Cell is exposed to such HF / RF under an instantaneous magnetic field it should alter many cell parameters, including its resting Trans Membrane Potentials (TMP). Cellular activity is closely linked with the TMP. TMP plays an Important role in the synthesis of proteins and it plays a significant role in the basic mechanism of mitosis (cell division) control. Powerful Mathematical Models and real time simulation in combination with MRI data of the tissue is used to precisely alter transmembrane potentials of target tissue. Altering the Trans Membrane Potential (TMP) is a complex process. Trans Membrane Potential of various cells are :-
  • -70 to -90 mV is the TMP in Healthy Cells.
  • -40 to -60 mV when Infected.
  • -20 to -30 mV in Cancer
  • 0 when the Cell dies.
     
back to top

THE OPERATION

There are 864 Guns in a Cytotron® RFQMR (new machine-whole body machine), that shoot RF beams, that are precisely focused on the target area. These beams alter the cell membrane potential, thus starting or stopping Cell Division (Mitosis) in a controlled manner. The desired exposure characteristics (like the cartilage to bone gap, skin to cartilage distance, Name, age, gender, height and weight etc.,) are fed into the computer. The computer then computes various wave front and spin frequencies, pulse amplitudes, field strength etc. There after the operator precisely focuses the beams on the required site. Currently 3 Clinical Trials on 490 patients treated with RFQMR for Osteoarthritis and Cancer have been completed with outstanding outcomes. The Cytotron® System has been cleared regarding the relative safety standards in India. Several systems has been positioned in different countries to provide health services.
     
back to top

THE INVENTOR
The team that developed Cytotron® after years of research at CARD was headed by Dr Rajah Vijay Kumar DSc. Dr Kumar is a pioneering researcher and an opinion leader in the field of Biophysics and Radiobiology. Specialised in Medical Engineering, he has worked for more than fifteen years on regenerative tissue engineering and high speed biological data acquisition, modeling and simulation of the human cardiovascular system. The many patents held by him include the Realistic Geometry Cartographic Imaging (RGCI) which finds applications from medical science to tsunami detection, and the Cytotron® which is considered an important milestone in radiobiology and tissue engineering. His work on Nanotechnology has sparked off a new technique in selective tissue destruction with a "nanoblaster" that is undergoing laboratory trials. He is currently the Director and Chief Scientific Officer of the Center for Advanced Research & Development (CARD) and the Chairman of Scalene Cybernetics Limited, Bangalore, India.

     
back to top

scalene asia pacific sdn bhd © 2007 • Disclaimer